Found: 24
Select item for more details and to access through your institution.
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60169-5
- By:
- Publication type:
- Article
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.
- Published in:
- Journal of Clinical Immunology, 2024, v. 44, n. 2, p. 1, doi. 10.1007/s10875-023-01642-0
- By:
- Publication type:
- Article
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies.
- Published in:
- Nutrients, 2023, v. 15, n. 16, p. 3498, doi. 10.3390/nu15163498
- By:
- Publication type:
- Article
Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 125, doi. 10.1002/jha2.635
- By:
- Publication type:
- Article
Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.962535
- By:
- Publication type:
- Article
B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 739, doi. 10.1002/jha2.475
- By:
- Publication type:
- Article
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e498, doi. 10.1016/j.clml.2022.01.007
- By:
- Publication type:
- Article
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 3019, doi. 10.3390/cancers14123019
- By:
- Publication type:
- Article
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study.
- Published in:
- HIV Medicine, 2022, v. 23, n. 5, p. 564, doi. 10.1111/hiv.13207
- By:
- Publication type:
- Article
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review).
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5208, doi. 10.3390/cancers13205208
- By:
- Publication type:
- Article
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3550, doi. 10.1007/s00259-021-05348-6
- By:
- Publication type:
- Article
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019.
- Published in:
- Intensive Care Medicine Experimental, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40635-021-00409-4
- By:
- Publication type:
- Article
Comparison of Circular and Parallel-Plated Membrane Lungs for Extracorporeal Carbon Dioxide Elimination.
- Published in:
- Membranes, 2021, v. 11, n. 6, p. 398, doi. 10.3390/membranes11060398
- By:
- Publication type:
- Article
Current Treatment Options in CLL.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2468, doi. 10.3390/cancers13102468
- By:
- Publication type:
- Article
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.637161
- By:
- Publication type:
- Article
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 100, doi. 10.1111/ejh.13526
- By:
- Publication type:
- Article
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.604685
- By:
- Publication type:
- Article
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.580364
- By:
- Publication type:
- Article
Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01578
- By:
- Publication type:
- Article
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1535, doi. 10.1007/s00262-020-02564-1
- By:
- Publication type:
- Article
Spontaneous regression of a plasmablastic lymphoma with MYC rearrangement.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e203, doi. 10.1111/bjh.16082
- By:
- Publication type:
- Article